Broncho-alveolar macrophages express chemokines associated with leukocyte migration in a mouse model of asthma

Cellular Immunology

Volumn 281, Issue 2, 2013, Pages 159-169

  Siddiqui, Shafiuddin ^a,c   Secor, Eric R ^b   Silbart, Lawrence K ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

Author keywords

Allergy; Alveolar macrophage; Asthma; Chemokine; Eosinophil; Migration

Indexed keywords

ADAM PROTEIN; AQUAPORIN 9; ARGINASE; CHEMOKINE; EOSINOPHIL ASSOCIATED RIBONUCLEASE A FAMILY MEMBER 11; EOTAXIN; EOTAXIN 2; FC RECEPTOR IIB; INTERLEUKIN 17 RECEPTOR; LEUKOTRIENE B 1 RECEPTOR; LEUKOTRIENE RECEPTOR; MATRIX METALLOPROTEINASE 14; MONOCYTE CHEMOTACTIC PROTEIN 2; PROTEIN ADAM 8; RESISTIN; RESISTIN LIKE ALPHA; RIBONUCLEASE A; RNA; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIA; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; GOBLET CELL; HYPERPLASIA; LEUKOCYTE; LEUKOCYTE MIGRATION; LUNG ALVEOLUS MACROPHAGE; LUNG INTERSTITIUM; MOUSE; MUCUS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL MOVEMENT; CHEMOKINE CCL24; CHEMOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FEMALE; GENE EXPRESSION PROFILING; GOBLET CELLS; LEUKOCYTE COUNT; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVALBUMIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84877903551     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.03.001     Document Type: Article

References (60)

1. Eder W., Ege M.J., von Mutius E. The asthma epidemic. The New England Journal of Medicine 2006, 355:2226-2235.
2. Busse W.W., Lemanske R.F. Asthma. The New England Journal of Medicine 2001, 344:350-362.
3. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nature Reviews 2008, 8:183-192.
4. Holgate S.T. Pathogenesis of asthma. Clinical and Experimental Allergy 2008, 38:872-897.
5. Holt P.G., Macaubas C., Stumbles P.A., Sly P.D. The role of allergy in the development of asthma. Nature 1999, 402:B12-B17.
6. Corry D.B., Kheradmand F. Induction and regulation of the IgE response. Nature 1999, 402:B18-B23.
7. Galli S.J., Tsai M., Piliponsky A.M. The development of allergic inflammation. Nature 2008, 454:445-454.
8. Gould H.J., Sutton B.J. IgE in allergy and asthma today. Nature Reviews 2008, 8:205-217.
9. Rothenberg M.E., Hogan S.P. The eosinophil. Annual Review of Immunology 2006, 24:147-174.
10. Williams T.J. The eosinophil enigma. The Journal of Clinical Investigation 2004, 113:507-509.
11. Rothenberg M.E. Eosinophilia. The New England Journal of Medicine 1998, 338:1592-1600.
12. Scott K.A., Wardlaw A.J. Eosinophilic airway disorders. Seminars in Respiratory and Critical Care Medicine 2006, 27:128-133.
13. Cohn L., Elias J.A., Chupp G.L. Asthma: mechanisms of disease persistence and progression. Annual Review of Immunology 2004, 22:789-815.
14. Lefrancois L., Puddington L. Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo. Annual Review of Immunology 2006, 24:681-704.
15. Medoff B.D., Thomas S.Y., Luster A.D. T cell trafficking in allergic asthma: the ins and outs. Annual Review of Immunology 2007.
16. Pichavant M., Goya S., Meyer E.H., Johnston R.A., Kim H.Y., Matangkasombut P., Zhu M., Iwakura Y., Savage P.B., DeKruyff R.H., Shore S.A., Umetsu D.T. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. The Journal of Experimental Medicine 2008, 205:385-393.
17. Iwamura C., Nakayama T. Role of alpha-galactosylceramide-activated valpha14 natural killer T cells in the regulation of allergic diseases. Allergology International 2007, 56:1-6.
18. Akbari O., Stock P., Meyer E., Kronenberg M., Sidobre S., Nakayama T., Taniguchi M., Grusby M.J., DeKruyff R.H., Umetsu D.T. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nature Medicine 2003, 9:582-588.
19. Miyahara N., Swanson B.J., Takeda K., Taube C., Miyahara S., Kodama T., Dakhama A., Ott V.L., Gelfand E.W. Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Nature Medicine 2004, 10:865-869.
20. Saetta M., Turato G. Airway pathology in asthma. The European Respiratory Journal 2001, 34:18s-23s.
21. Haley K.J., Sunday M.E., Wiggs B.R., Kozakewich H.P., Reilly J.J., Mentzer S.J., Sugarbaker D.J., Doerschuk C.M., Drazen J.M. Inflammatory cell distribution within and along asthmatic airways. American Journal of Respiratory and Critical Care Medicine 1998, 158:565-572.
22. de Magalhaes Simoes S., dos Santos M.A., da Silva Oliveira M., Fontes E.S., Fernezlian S., Garippo A.L., Castro I., Castro F.F., de Arruda Martins M., Saldiva P.H., Mauad T., Dolhnikoff M. Inflammatory cell mapping of the respiratory tract in fatal asthma. Clinical and Experimental Allergy 2005, 35:602-611.
23. Van Vyve T., Chanez P., Lacoste J.Y., Bousquet J., Michel F.B., Godard P. Comparison between bronchial and alveolar samples of bronchoalveolar lavage fluid in asthma. Chest 1992, 102:356-361.
24. Kraft M., Djukanovic R., Wilson S., Holgate S.T., Martin R.J. Alveolar tissue inflammation in asthma. American Journal of Respiratory and Critical Care Medicine 1996, 154:1505-1510.
25. Kraft M., Martin R.J., Wilson S., Djukanovic R., Holgate S.T. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. American Journal of Respiratory and Critical Care Medicine 1999, 159:228-234.
26. Kraft M., Pak J., Martin R.J., Kaminsky D., Irvin C.G. Distal lung dysfunction at night in nocturnal asthma. American Journal of Respiratory and Critical Care Medicine 2001, 163:1551-1556.
27. Martin R.J. Small airway and alveolar tissue changes in nocturnal asthma. American Journal of Respiratory and Critical Care Medicine 1998, 157:S188-S190.
28. Shigemitsu H., Afshar K. Nocturnal asthma. Current Opinion in Pulmonary Medicine 2007, 13:49-55.
29. Sutherland E.R. Nocturnal asthma. Journal of Allergy and Clinical Immunology 2005, 116:1179-1186.
30. Sheppard D. Killed by leukocytes that do not know when to leave. Nature Immunology 2002, 3:337-338.
31. Corry D.B., Kiss A., Song L.Z., Song L., Xu J., Lee S.H., Werb Z., Kheradmand F. Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB Journal 2004, 18:995-997.
32. Corry D.B., Rishi K., Kanellis J., Kiss A., Song L.Z., Xu J., Feng L., Werb Z., Kheradmand F. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nature Immunology 2002, 3:347-353.
33. Gerwin N., Gonzalo J.A., Lloyd C., Coyle A.J., Reiss Y., Banu N., Wang B., Xu H., Avraham H., Engelhardt B., Springer T.A., Gutierrez-Ramos J.C. Prolonged eosinophil accumulation in allergic lung interstitium of ICAM-2 deficient mice results in extended hyperresponsiveness. Immunity 1999, 10:9-19.
34. Munger J.S., Huang X., Kawakatsu H., Griffiths M.J., Dalton S.L., Wu J., Pittet J.F., Kaminski N., Garat C., Matthay M.A., Rifkin D.B., Sheppard D. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999, 96:319-328.
35. Takabayshi K., Corr M., Hayashi T., Redecke V., Beck L., Guiney D., Sheppard D., Raz E. Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity 2006, 24:475-487.
36. Fels A.O., Cohn Z.A. The alveolar macrophage. Journal of Applied Physiology 1986, 60:353-369.
37. Peters-Golden M. The alveolar macrophage: the forgotten cell in asthma. American Journal of Respiratory Cell and Molecular Biology 2004, 31:3-7.
38. Moreira A.P., Hogaboam C.M. Macrophages in allergic asthma: fine-tuning their pro- and anti-inflammatory actions for disease resolution. Journal of Interferon and Cytokine Research 2011, 31:485-491.
39. Pope S.M., Fulkerson P.C., Blanchard C., Akei H.S., Nikolaidis N.M., Zimmermann N., Molkentin J.D., Rothenberg M.E. Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. The Journal of Biological Chemistry 2005, 280:13952-13961.
40. Siddiqui S., Morris J., Avery N., Wyand S., Rood D., Silbart L.K. Pulmonary eosinophilia correlates with allergen deposition to the lower respiratory tract in a mouse model of asthma. Clinical and Experimental Allergy 2008, 38:1381-1390.
41. Watanabe J., Miyazaki Y., Zimmerman G.A., Albertine K.H., McIntyre T.M. Endotoxin contamination of ovalbumin suppresses murine immunologic responses and development of airway hyper-reactivity. The Journal of Biological Chemistry 2003, 278:42361-42368.
42. Lewis C.C., Yang J.Y., Huang X., Banerjee S.K., Blackburn M.R., Baluk P., McDonald D.M., Blackwell T.S., Nagabhushanam V., Peters W., Voehringer D., Erle D.J. Disease-specific gene expression profiling in multiple models of lung disease. American Journal of Respiratory and Critical Care Medicine 2008, 177:376-387.
43. Park S.G., Choi J.W., Kim H.J., Roh G.S., Bok J., Go M.J., Kwack K., Oh B., Kim Y. Genome-wide profiling of antigen-induced time course expression using murine models for acute and chronic asthma. International Archives of Allergy and Immunology 2007, 146:44-56.
44. Zimmermann N., King N.E., Laporte J., Yang M., Mishra A., Pope S.M., Muntel E.E., Witte D.P., Pegg A.A., Foster P.S., Hamid Q., Rothenberg M.E. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. The Journal of Clinical Investigation 2003, 111:1863-1874.
45. Zimmermann N., Mishra A., King N.E., Fulkerson P.C., Doepker M.P., Nikolaidis N.M., Kindinger L.E., Moulton E.A., Aronow B.J., Rothenberg M.E. Transcript signatures in experimental asthma: identification of STAT6-dependent and - independent pathways. The Journal of Immunology 2004, 172:1815-1824.
46. Gordon S. Alternative activation of macrophages. Nature Reviews 2003, 3:23-35.
47. Li H., Romieu I., Sienra-Monge J.J., Ramirez-Aguilar M., Estela Del Rio-Navarro B., Kistner E.O., Gjessing H.K., Lara-Sanchez Idel C., Chiu G.Y., London S.J. Genetic polymorphisms in arginase I and II and childhood asthma and atopy. The Journal of Allergy and Clinical Immunology 2006, 117:119-126.
48. Reese T.A., Liang H.E., Tager A.M., Luster A.D., Van Rooijen N., Voehringer D., Locksley R.M. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 2007, 447:92-96.
49. Voehringer D., van Rooijen N., Locksley R.M. Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages. Journal of Leukocyte Biology 2007, 81:1434-1444.
50. Umetsu D.T., McIntire J.J., Akbari O., Macaubas C., DeKruyff R.H. Asthma: an epidemic of dysregulated immunity. Nature Immunology 2002, 3:715-720.
51. Barrios R.J., Kheradmand F., Batts L., Corry D.B. Asthma: pathology and pathophysiology. Archives of Pathology and Laboratory Medicine 2006, 130:447-451.
52. Havenith C.E., Breedijk A.J., van Miert P.P., Blijleven N., Calame W., Beelen R.H., Hoefsmit E.C. Separation of alveolar macrophages and dendritic cells via autofluorescence: phenotypical and functional characterization. Journal of Leukocyte Biology 1993, 53:504-510.
53. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nature Reviews 2005, 5:953-964.
54. Walsh E.R., Sahu N., Kearley J., Benjamin E., Kang B.H., Humbles A., August A. Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma. The Journal of Experimental Medicine 2008, 205:1285-1292.
55. Lloyd C.M., Delaney T., Nguyen T., Tian J., Martinez A.C., Coyle A.J., Gutierrez-Ramos J.C. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. The Journal of Experimental Medicine 2000, 191:265-274.
56. Shang X.Z., Chiu B.C., Stolberg V., Lukacs N.W., Kunkel S.L., Murphy H.S., Chensue S.W. Eosinophil recruitment in type-2 hypersensitivity pulmonary granulomas: source and contribution of monocyte chemotactic protein-3 (CCL7). The American Journal of Pathology 2002, 161:257-266.
57. Crowell R.E., Heaphy E., Valdez Y.E., Mold C., Lehnert B.E. Alveolar and interstitial macrophage populations in the murine lung. Experimental Lung Research 1992, 18:435-446.
58. Prokhorova S., Lavnikova N., Laskin D.L. Functional characterization of interstitial macrophages and subpopulations of alveolar macrophages from rat lung. Journal of Leukocyte Biology 1994, 55:141-146.
59. Lavnikova N., Prokhorova S., Helyar L., Laskin D.L. Isolation and partial characterization of subpopulations of alveolar macrophages, granulocytes, and highly enriched interstitial macrophages from rat lung. American Journal of Respiratory Cell and Molecular Biology 1993, 8:384-392.
60. Orme J., Mohan C. Macrophage subpopulations in systemic lupus erythematosus. Discovery Medicine 2012, 13(69):151-158.